Passage BIO, Inc. filed Form S-4
- Filed on October 9, 2026
- Form S-4 submitted
- CIK: 0001787297
PASG
Passage BIO, Inc. SEC filings
Every EDGAR filing for Passage BIO, Inc. (PASG), newest first, with AI summaries and stories.
- Ticker
- PASG
- CIK
- 1787297
- Latest filing
- 6d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEEFFECTPassage BIO, Inc.PASGLIVE ROUTINE424B3Passage BIO, Inc.PASGLIVE Passage Bio to merge with Remix
- Merger with Remix Therapeutics, Inc.
- Passage Bio to change name to Remix Therapeutics, Inc.
- Exchange ratio of 0.1727 shares of Passage Bio for each Remix share
ROUTINES-4/APassage BIO, Inc.PASGLIVE Passage BIO merges with Remix
- Amended merger agreement dated Sept 2, 2026
- Merger exchange ratio of 0.1727 shares
- Concurrent financing of $100M expected
ROUTINES-4/APassage BIO, Inc.PASGLIVE Passage BIO merges with Remix
- Amended merger agreement dated 2026-09-02
- Merger exchange ratio of 0.1727 shares
- Concurrent financing expected to raise $100M
ROUTINES-4/APassage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINE425Passage BIO, Inc.PASGLIVE ROUTINES-4/APassage BIO, Inc.PASGLIVE ROUTINESCHEDULE 13G/APassage BIO, Inc.PASGLIVE Ownership stake disclosure by Vestal Point Capital, LP (amended)
Vestal Point Capital, LP, filed by
NOTABLE10-QPassage BIO, Inc.PASGLIVE ROUTINE425Passage BIO, Inc.PASGLIVE NOTABLES-4Passage BIO, Inc.PASGLIVE NOTABLESCHEDULE 13DPassage BIO, Inc.PASGLIVE Ownership stake disclosure by Lynx1 Capital Management LP
Lynx1 Capital Management LP, filed by
ROUTINE4Passage BIO, Inc.PASGLIVE Weston Nichols, insider filing for PASG
Weston Nichols, reporting · Lynx1 Capital Management LP, reporting
ROUTINESCHEDULE 13GPassage BIO, Inc.PASGLIVE Ownership stake disclosure by Baselake Partners, LP
Baselake Partners, LP, filed by
ROUTINE425Passage BIO, Inc.PASGLIVE ROUTINE425Passage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINE4Passage BIO, Inc.PASGLIVE 6 insider filings
Dolan Sondhi, insider filing for PASG
Show all 6
- 4Insider filing for PASG
- 4Insider filing for PASG
- 4Insider filing for PASG
- 4Insider filing for PASG
- 4Insider filing for PASG
- 4Insider filing for PASG
Dolan Sondhi, reporting
NOTABLE10-QPassage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINEARSPassage BIO, Inc.PASGLIVE ROUTINEDEFA14APassage BIO, Inc.PASGLIVE ROUTINEDEF 14APassage BIO, Inc.PASGLIVE ROUTINE4Passage BIO, Inc.PASGLIVE 2 insider filings
Kathleen Borthwick, insider filing for PASG
Show all 2
- 4Insider filing for PASG
- 4Insider filing for PASG
Kathleen Borthwick, reporting
ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINES-8Passage BIO, Inc.PASGLIVE NOTABLE10-KPassage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINE4Passage BIO, Inc.PASGLIVE 2 insider filings
William Chou, insider filing for PASG
Show all 2
- 4Insider filing for PASG
- 4Insider filing for PASG
William Chou, reporting
ROUTINE8-KPassage BIO, Inc.PASGLIVE ROUTINE144Passage BIO, Inc.PASGLIVE William Chou, planned sale of PASG shares
William Chou, reporting
ROUTINE4Passage BIO, Inc.PASGLIVE 2 insider filings
Kathleen Borthwick, insider filing for PASG
Show all 2
- 4Insider filing for PASG
- 4Insider filing for PASG
Kathleen Borthwick, reporting
ROUTINESCHEDULE 13G/APassage BIO, Inc.PASGLIVE Ownership stake disclosure by Lynx1 Capital Management LP (amended)
Lynx1 Capital Management LP, filed by
NOTABLE10-QPassage BIO, Inc.PASGLIVE ROUTINE8-KPassage BIO, Inc.PASGLIVE